Table: Torii Pharmaceutical - 9-MTH parent results
Oct 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2023 Sep 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 39.13 35.32 54.00
(+10.8 pct) (+10.4 pct)
Operating 3.21 4.07 4.50
(-21.0 pct) (+28.9 pct) (-18.8 pct)
Recurring 3.32 3.92 4.70
(-15.4 pct) (+20.3 pct) (-15.1 pct)
Net 2.37 2.86 3.40
(-17.1 pct) (+27.6 pct) (-13.8 pct)
EPS 84.27 yen 101.66 yen 120.99 yen
Ann Div 100.00 yen 100.00 yen
-Q2 div 50.00 yen 24.00 yen
-Q4 div 76.00 yen 50.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)